Загрузка...
Role of indacaterol and the newer very long-acting β2-agonists in patients with stable COPD: a review
Bronchodilators are central drugs in the management of patients with chronic obstructive pulmonary disease (COPD). Indacaterol was the first agent of the novel family of very long-acting β2-agonists to be used as an inhaled bronchodilator for COPD and provides 24-hour therapeutic action, thus allowi...
Сохранить в:
| Главные авторы: | , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Dove Medical Press
2013
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3785397/ https://ncbi.nlm.nih.gov/pubmed/24082783 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S49179 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|